Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-incisional multimodal injection for post-operative pain in lumbar spine surgery
NCT03513445Phase 3Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jun 2018
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of morphine, epinephrine, ropivacaine in postoperative pain, sponsored by University of Minnesota. Planned start Jun 2018; status: withdrawn.
02
Drugs
morphineepinephrineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03513445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513445.